|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61P 35/00 |
| (11) | Patento numeris | 3368067 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16795498.1 |
| Europos patento paraiškos padavimo data | 2016-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-09-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/059680 |
| Data | 2016-10-31 |
| (87) | Numeris | WO 2017/075570 |
| Data | 2017-05-04 |
| (30) | Numeris | Data | Šalis |
| 201562248964 P | 2015-10-30 | US |
| (72) |
WOOD, Lauren, V., US
ROBERSON, Brenda, D., US
BERZOFSKY, Jay, A., US
MORRIS, John, C., US
STEEL, Jason, C., AU
TERABE, Masaki, US
BRENNER, Malcolm K., US
|
| (73) |
Baylor College of Medicine,
One Baylor Plaza, Houston, TX 77030,
US
The United States of America, as represented by the Secretary, Department of Health and Human Services, National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20852-7660, US |
| (54) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS |
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS |